Venture Life Group plc (VLG.L) Stock

VLG.L logo

Venture Life Group plc

VLG.LUnited Kingdom
Healthcare

Company profile

Venture Life Group reports about 63 full-time employees.

Figures from company filings; latest fiscal year ended December 31, 2024.

About Venture Life Group plc

Venture Life Group plc develops and commercializes healthcare products in the United Kingdom. The company offers women's healthcare products, including BV treatment gel and pessaries; intimate daily wash and soothing cream; moisture gel and plus pessaries; and thrush cream under Balance Activ name. It also provides glucose management products, such as Lift Glucose shots and tablets for the immediate treatment of hypoglycaemia and preventing hypos; and Glucogel for the treatment of hypoglycaemia. In addition, the company offers ENT care products comprising Earol, for the removal of ear wax; EarolSwim, an invisible ear plugs for protecting the ears from water ingress; and Baby Earol, an ear spray for babies under the Earol and EarolSwim brands. Further, it provides oncology support products, such as Pomi-T for the management of prostate-specific antigen levels in prostate cancer; and Gelclair, a muco-adhesive oral rinse for the treatment of Oral Mucositis. The company operates in Germany, the Netherlands, Norway, France, Sweden, Denmark, Lithuania, rest of Europe, the United States, Canada, Brazil, Ireland, and internationally. Venture Life Group plc was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.

Largest shareholders

  • Slater Investments Ltd.14.98%
  • BGF Investment Management Ltd.9.64%
  • Close Brothers Asset Management (Guernsey) Ltd.8.00%
  • Hargreaves Lansdown Asset Management Ltd.7.61%
  • Corient Investment Management Ltd.7.01%

Share of the company, as of September 25, 2026

Leadership

  • Jeremy Anthony Philip Randall ACA — Co-Founder, CEO & Executive Director, 61
  • Daniel James Wells — CFO & Director, 38
  • Peter Robert Jackson — Chief Digital and Technology Officer & Director, 57
  • Katherine Louise Bache — Chief Marketing & Innovation Officer and Director, 44
  • Ben Colman — Director of Corporate Development

What companies are similar to Venture Life Group?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Hikma Pharmaceuticals PLC (HIK.L), International Biotechnology Ord (IBT.L), Beximco Pharmaceuticals Limited (BXP.L), Poolbeg Pharma PLC (POLB.L).

Company Information

SectorHealthcare
IndustryMulti-Therapeutic Drug Manufacturing
Employees63
Founded2010
IPO DateMar 28, 2014
IPO StatusPublic
HeadquartersBracknell, United Kingdom
FoundersJerry Randall
ExchangeLSE
TimezoneEurope/London (GMT)

Contact & Links

Address
12 The Courtyard, Bracknell, RG12 2XB
Phone
44 13 4457 8004
Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.

Data as of .

How to cite: DataPorium, “Venture Life Group plc (VLG.L)”, data as of Sep 25, 2026, https://dataporium.tech/stocks/VLG.L

LinkedInLinkedInXXYouTubeYouTube